Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo.

Zhang, Wei

Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo. [electronic resource] - Oncology reports Nov 2014 - 1913-22 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1791-2431

10.3892/or.2014.3418 doi


ADAM Proteins--genetics
ADAM10 Protein
Amyloid Precursor Protein Secretases--genetics
Animals
Apoptosis
Carcinoma, Hepatocellular--drug therapy
Cell Proliferation--drug effects
Drug Resistance, Neoplasm--drug effects
Female
Gene Knockout Techniques
Genetic Vectors--administration & dosage
Hep G2 Cells
Humans
In Vitro Techniques
Liver Neoplasms--drug therapy
Membrane Proteins--genetics
Mice
Mice, Inbred BALB C
Neoplasm Transplantation
Niacinamide--administration & dosage
Phenylurea Compounds--administration & dosage
Plasmids--genetics
RNA, Small Interfering--metabolism
Sorafenib